Medline MDLN
NASDAQ MDLN
$40.40 +0.42 (+1.04%)
As of: Nov 13, 2026 · 11:57 AM EST

Medline (MDLN) Amortization of Deferred Charges (2025 - 2026)

Updated

Analysis

Medline (MDLN) Amortization of Deferred Charges (2025 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 259.20 Bn 235.84 Bn 5.13 Bn
2 Abbott Laboratories 185.80 Bn 160.26 Bn 7.39 Bn
3 Danaher 162.11 Bn 141.76 Bn 3.84 Bn
4 Intuitive Surgical 155.35 Bn 135.64 Bn 2.08 Bn
5 Medtronic 131.92 Bn 97.43 Bn 6.34 Bn
6 Stryker 119.74 Bn 105.93 Bn 4.25 Bn
7 Boston Scientific 64.30 Bn 59.73 Bn 3.43 Bn
8 Edwards Lifesciences 61.64 Bn 44.85 Bn 1.35 Bn
9 Agilent Technologies 48.79 Bn 41.68 Bn 1.04 Bn
10 Medline 35.34 Bn 24.88 Bn 1.93 Bn
Historic Data

Historic Data

Download Data
DateValue
Sep 26, 2026 10.00 Mn
Jun 27, 2026 13.00 Mn
Mar 28, 2026 11.00 Mn
Dec 31, 2025 14.00 Mn
Sep 27, 2025 15.00 Mn
Jun 28, 2025 15.00 Mn
Mar 29, 2025 15.00 Mn
API Access

Medline Amortization of Deferred Charges API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=amortization-of-deferred-charges&ticker=MDLN&period=max&api_key=YOUR_API_KEY